EYSINS, Switzerland, April 3, 2025 /PRNewswire/ --Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® ...
The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ -- AliveDx ...
Laboratory diagnosis of respiratory viruses, including the novel SARS-CoV-2 coronavirus (COVID-19), requires rapid, specific diagnostic testing technology. For SARS-CoV-2, an accurate diagnosis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results